JP2017503749A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017503749A5 JP2017503749A5 JP2016519779A JP2016519779A JP2017503749A5 JP 2017503749 A5 JP2017503749 A5 JP 2017503749A5 JP 2016519779 A JP2016519779 A JP 2016519779A JP 2016519779 A JP2016519779 A JP 2016519779A JP 2017503749 A5 JP2017503749 A5 JP 2017503749A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- unsubstituted
- cyclic
- acyclic
- branched
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361885384P | 2013-10-01 | 2013-10-01 | |
| US61/885,384 | 2013-10-01 | ||
| US201461934618P | 2014-01-31 | 2014-01-31 | |
| US61/934,618 | 2014-01-31 | ||
| PCT/US2014/058680 WO2015051030A2 (en) | 2013-10-01 | 2014-10-01 | Stabilized polypeptides and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017503749A JP2017503749A (ja) | 2017-02-02 |
| JP2017503749A5 true JP2017503749A5 (enExample) | 2018-08-30 |
Family
ID=52779285
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016519779A Pending JP2017503749A (ja) | 2013-10-01 | 2014-10-01 | 安定化されたポリペプチドおよびその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20160244494A1 (enExample) |
| EP (1) | EP3052520A4 (enExample) |
| JP (1) | JP2017503749A (enExample) |
| CN (1) | CN106103472A (enExample) |
| IL (1) | IL244810A0 (enExample) |
| WO (1) | WO2015051030A2 (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7192713B1 (en) | 1999-05-18 | 2007-03-20 | President And Fellows Of Harvard College | Stabilized compounds having secondary structure motifs |
| PL2118123T3 (pl) | 2007-01-31 | 2016-06-30 | Dana Farber Cancer Inst Inc | Stabilizowane peptydy p53 i ich zastosowania |
| JP5631201B2 (ja) | 2007-03-28 | 2014-11-26 | プレジデント アンド フェローズ オブ ハーバード カレッジ | ステッチングされたポリペプチド |
| KR102104762B1 (ko) | 2010-08-13 | 2020-04-24 | 에일러론 테라퓨틱스 인코포레이티드 | 펩티도미메틱 거대고리 |
| EP2768518A4 (en) | 2011-10-18 | 2015-05-27 | Aileron Therapeutics Inc | PEPTIDOMIMETIC MACROCYCLES |
| RU2642299C2 (ru) | 2012-02-15 | 2018-01-24 | Эйлерон Терапьютикс, Инк. | P53 пептидомиметические макроциклы |
| CA2864120A1 (en) | 2012-02-15 | 2013-08-22 | Aileron Therapeutics, Inc. | Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles |
| WO2014138429A2 (en) | 2013-03-06 | 2014-09-12 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and use thereof in regulating hif1alpha |
| US20160303242A1 (en) | 2013-12-09 | 2016-10-20 | Durect Corporation | Pharmaceutically Active Agent Complexes, Polymer Complexes, and Compositions and Methods Involving the Same |
| EP3197478A4 (en) | 2014-09-24 | 2018-05-30 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and uses thereof |
| CN107106642B (zh) | 2014-09-24 | 2021-02-26 | 艾瑞朗医疗公司 | 拟肽大环化合物及其制剂 |
| JP2018516844A (ja) | 2015-03-20 | 2018-06-28 | エルロン・セラピューティクス・インコーポレイテッドＡｉｌｅｒｏｎ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． | ペプチド模倣大環状分子およびその使用 |
| US10059741B2 (en) | 2015-07-01 | 2018-08-28 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
| WO2018089648A2 (en) | 2016-11-09 | 2018-05-17 | Ohio State Innovation Foundation | Di-sulfide containing cell penetrating peptides and methods of making and using thereof |
| US10913773B2 (en) | 2016-11-22 | 2021-02-09 | Ohio State Innovation Foundation | Bicyclic peptidyl inhibitor of tumor necrosis factor-alpha |
| US11352394B2 (en) | 2016-11-22 | 2022-06-07 | Ohio State Innovation Foundation | Cyclic cell penetrating peptides comprising beta-hairpin motifs and methods of making and using thereof |
| EA202090513A1 (ru) | 2017-09-07 | 2020-08-24 | Фог Фармасьютикалз, Инк. | Агенты, модулирующие функции бета-катенина, и связанные способы |
| WO2019070962A1 (en) | 2017-10-04 | 2019-04-11 | Ohio State Innovation Foundation | BICYCLIC PEPTIDE INHIBITORS |
| WO2019118893A1 (en) | 2017-12-15 | 2019-06-20 | Dana-Farber Cancer Institute, Inc. | Stabilized peptide-mediated targeted protein degradation |
| WO2019136209A1 (en) * | 2018-01-05 | 2019-07-11 | President And Fellows Of Harvard College | Stabilized polypeptides and uses thereof |
| US11793884B2 (en) | 2018-01-29 | 2023-10-24 | Ohio State Innovation Foundation | Cyclic peptidyl inhibitors of CAL-PDZ binding domain |
| WO2019157131A1 (en) | 2018-02-07 | 2019-08-15 | Dana-Farber Cancer Institute, Inc. | Cell-permeable stapled peptide modules for cellular delivery |
| WO2019217682A1 (en) | 2018-05-09 | 2019-11-14 | Ohio State Innovation Foundation | Cyclic cell-penetrating peptides with one or more hydrophobic residues |
| WO2020023502A1 (en) | 2018-07-23 | 2020-01-30 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and uses thereof |
| EP3838924A4 (en) * | 2018-07-31 | 2022-06-22 | Lemonex Inc. | POLYPEPTIDE DELIVERY COMPOSITION |
| BR112021003113A2 (pt) | 2018-08-20 | 2021-05-11 | Fog Pharmaceuticals, Inc. | coleções de peptídeos, agentes de peptídeos e métodos de uso dos mesmos |
| CN116710116A (zh) * | 2020-10-30 | 2023-09-05 | Ｘｅｎｏ－Ｉｎｔｅｒｆａｃｅ株式会社 | β折叠股桥肽 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001029247A1 (en) * | 1999-10-15 | 2001-04-26 | Avatar Medical, Llc | Stabilized proteins |
| WO2005044839A2 (en) * | 2003-11-05 | 2005-05-19 | Dana-Farber Cancer Institute, Inc. | Stabilized alpha helical peptides and uses thereof |
| CN100595277C (zh) * | 2003-11-15 | 2010-03-24 | 波利弗尔有限公司 | 模板固定的β发夹环模拟物及其在噬菌体展示中的用途 |
| US7202332B2 (en) * | 2004-05-27 | 2007-04-10 | New York University | Methods for preparing internally constrained peptides and peptidomimetics |
| WO2006069001A2 (en) * | 2004-12-20 | 2006-06-29 | Baylor College Of Medicine | Structural requirements for stat3 binding and recruitment to phosphototyrosine ligands |
| JP5631201B2 (ja) * | 2007-03-28 | 2014-11-26 | プレジデント アンド フェローズ オブ ハーバード カレッジ | ステッチングされたポリペプチド |
| US20110144306A1 (en) * | 2008-07-23 | 2011-06-16 | President And Fellows Of Harvard College | Ligation of stapled polypeptides |
| BR112012000867A2 (pt) * | 2009-07-13 | 2019-09-24 | Harvard College | "polipeptídeos bifuncional costurado e uso do mesmo" |
| US20130177979A1 (en) * | 2010-06-22 | 2013-07-11 | University Of Central Florida Research Foundation, Inc. | Methods and compositions for cell permeable stat3 inhibitor |
-
2014
- 2014-10-01 WO PCT/US2014/058680 patent/WO2015051030A2/en not_active Ceased
- 2014-10-01 JP JP2016519779A patent/JP2017503749A/ja active Pending
- 2014-10-01 US US15/026,473 patent/US20160244494A1/en not_active Abandoned
- 2014-10-01 CN CN201480065507.3A patent/CN106103472A/zh active Pending
- 2014-10-01 EP EP14850442.6A patent/EP3052520A4/en not_active Withdrawn
-
2016
- 2016-03-29 IL IL244810A patent/IL244810A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7490735B2 (ja) | ジスルフィド含有細胞膜透過ペプチド並びにその製造方法及び使用方法 | |
| ES2654551T3 (es) | Anticuerpo contra el CSF-1R | |
| DK2678037T3 (en) | Branched linker for protein pharmaceutical conjugates | |
| ES2882634T3 (es) | Compuestos peptídicos y conjugados con péptidos para el tratamiento del cáncer mediante quimioterapia mediada por receptores | |
| Baumruck et al. | Chemical synthesis of membrane proteins: a model study on the influenza virus B proton channel | |
| JP2014506135A5 (enExample) | ||
| FI3354729T3 (fi) | Anti-garp-vasta-aine | |
| TW201915009A (zh) | 合成依特卡肽（Ｅｔｅｌｃａｌｃｅｔｉｄｅ）或其鹽類之方法 | |
| JP7780253B2 (ja) | ステープルペプチドの細胞内送達のためのポリペプチド接合体 | |
| EP3398957B1 (en) | Method for synthesizing etelcalcetide | |
| CN104130315B (zh) | 一种特异靶向her2蛋白的多肽 | |
| CN102510755A (zh) | 双功能钉接多肽和其用途 | |
| ITMI20100093A1 (it) | Peptidi ciclici che legano il recettore cxcr4 e relativi usi in campo medico e diagnostico | |
| CN111040020B (zh) | 一种烯烃硫醚类订书肽及其制备方法与应用 | |
| Qian et al. | Effects on polo-like kinase 1 polo-box domain binding affinities of peptides incurred by structural variation at the phosphoamino acid position | |
| Li et al. | Greener liquid-phase synthesis and the ACE inhibitory structure–activity relationship of an anti-SARS octapeptide | |
| Tung et al. | Peptide 2-formylthiophenol esters do not proceed through a Ser/Thr ligation pathway, but participate in a peptide aminolysis to enable peptide condensation and cyclization | |
| US10258695B2 (en) | Protein derivatization to endow cell penetration | |
| Mandal et al. | Structure–activity studies of phosphopeptidomimetic prodrugs targeting the Src homology 2 (SH2) domain of signal transducer and activator of transcription 3 (Stat3) | |
| Singh et al. | Synthesis and characterization of selenium (I/II) and tellurium (IV) derivatives of amino acids | |
| Atkinson et al. | Development of small cyclic peptides targeting the CK2α/β interface | |
| WO2015125892A1 (ja) | 蛋白質の標識化合物 | |
| JP7687711B2 (ja) | ネイティブケミカルライゲーションを用いる新規フロー合成方法 | |
| JP6707783B2 (ja) | ペプチド化合物及びペプチド化合物の製造方法 | |
| WO2019072231A1 (zh) | 核磁共振显像化合物、核磁共振显像剂及应用、以及核磁共振成像方法 |